SCHEMBL29369333

SCHEMBL29369333

CCC(=O)c1cc(Cl)c(F)cc1O[C@@H](CF)COCc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 4/20 0.37
PPARG P37231 3/20 0.37
MAPK14 Q16539 1/20 0.36
NPC1 O15118 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
PIM1 P11309 1/20 0.35
ABCB1 P08183 1/20 0.34
SCN9A Q15858 1/20 0.34
APOBEC3A P31941 1/20 0.34
APOBEC3G Q9HC16 1/20 0.34
CTSB P07858 1/20 0.34
UGCG Q16739 1/20 0.33
GRM5 P41594 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22823975 1.00 PPARA (0.37) PPARAPPARGMAPK14NPC1HPGD
SCHEMBL28688897 1.00 PPARA (0.37) PPARAPPARGMAPK14NPC1HPGD
SCHEMBL29368299 0.88 SMN1; SMN2 (0.35) NPC1HPGDRAB9ASMN1; SMN2ABCB1
SCHEMBL22823743 0.88 SMN1; SMN2 (0.35) NPC1HPGDRAB9ASMN1; SMN2ABCB1
SCHEMBL28672381 0.88 SMN1; SMN2 (0.35) NPC1HPGDRAB9ASMN1; SMN2ABCB1
SCHEMBL22823736 0.81 PTGER1 (0.40) NPC1HPGDRAB9ASMN1; SMN2KDM4E
SCHEMBL29368013 0.81 PTGER1 (0.40) NPC1HPGDRAB9ASMN1; SMN2KDM4E
SCHEMBL28673201 0.81 PTGER1 (0.40) NPC1HPGDRAB9ASMN1; SMN2KDM4E
SCHEMBL22823978 0.81 TSHR (0.33) PPARAPPARGSCN9A
SCHEMBL29602246 0.81 TSHR (0.33) PPARAPPARGSCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114008012-B Compounds for the treatment of neuromuscular disorders NMD制药股份公司 2025-02-25 CN disclosed
EP-3986852-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2022-04-27 EP disclosed
CN-114008012-A Compounds for the treatment of neuromuscular disorders NMD制药股份公司 2022-02-01 CN disclosed